Tudóstér: Somodi Sándor publikációi

Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Paragh, G., Harangi, M.: Associations between Serum Kallistatin Levels and Markers of Glucose Homeostasis, Inflammation, and Lipoprotein Metabolism in Patients with Type 2 Diabetes and Nondiabetic Obesity.
Int. J. Mol. Sci. 25 (11), 1-12, 2024.

Esze, R., Barna, S., Fülöp, P., Kempler, P., Mikó, M., Páll, D., Paragh, G., Somodi, S., Emri, M., Képes, Z., Garai, I., Káplár, M.: C-peptide: an essential ally in microvascular complications of type 2 diabetes mellitus and obesity.
Diabetol Metab Syndr. 16 (1), 2024.

Szekeres, R., Priksz, D., Bombicz, M., Pelles-Taskó, B., Szilágyi, A., Bernát, B., Pósa, A., Varga, B., Gesztelyi, R., Somodi, S., Szabó, Z., Szilvássy, Z., Juhász, B.: Exercise Types: Physical Activity Mitigates Cardiac Aging and Enhances Mitochondrial Function via PKG-STAT3-Opa1 Axis.
Aging Dis. [Epub ahead of print]2024.

Esze, R., Balkay, L., Barna, S., Egeresi, L., Emri, M., Páll, D., Paragh, G., Rajnai, L., Somodi, S., Képes, Z., Garai, I., Káplár, M.: Impact of Fat Distribution and Metabolic Diseases on Cerebral Microcirculation: a Multimodal Study on Type 2 Diabetic and Obese Patients.
J Clin Med. 13 (10), 1-14, 2024.

Káplár, M., Esze, R., Rajnai, L., Képes, Z., Balkay, L., Somodi, S., Paragh, G., Katkó, M., Emri, M., Garai, I., Fülöp, P.: Impact of liver fat content on serum levels of plasminogen activator inhibitor-1, fibroblast growth factor 21 and cerebral microcirculation in type 2 diabetes and obesity.

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, 2024.

Borbásné Sebestyén, V., Ratku, B., Ujvárosy, D., Lőrincz, H., Tari, D., Végh, L., Majai, G., Somodi, S., Páll, D., Szűcs, G., Harangi, M., Szabó, Z.: Progranulin, sICAM-1, and sVCAM-1 May Predict an Increased Risk for Ventricular Arrhythmias in Patients with Systemic Sclerosis.
Int. J. Mol. Sci. 25 (13), 1-13, 2024.

Ratku, B., Lőrincz, H., Csiha, S., Borbásné Sebestyén, V., Berta, E., Bodor, M., Nagy, E., Szabó, Z., Harangi, M., Somodi, S.: Serum afamin and its implications in adult growth hormone deficiency: a prospective GH-withdrawal study.
Front Endocrinol (Lausanne). 15 1-13, 2024.

Fésüs, A., Baluku, P., Sipos, É., Somodi, S., Berczi-Kun, E., Lekli, I., Bácskay, I., Benkő, R., Vaskó, A.: The effect of the antibiotic stewardship program (ASP) on community-acquired pneumonia (CAP): a before-after study.
Front. Pharm. 15 1-12, 2024.

Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14 1-9, 2023.

Ratku, B., Borbásné Sebestyén, V., Szelesné Árokszállási, A., Erdei, A., Berta, E., Szabó, Z., Bodor, M., Nagy, E., Somodi, S.: A felnőttkori növekedésihormon-hiány szív- és érrendszeri szövődményei.
Orv. hetil. 164 (41), 1616-1627, 2023.

Lőrincz, H., Ratku, B., Csiha, S., Seres, I., Szabó, Z., Katona, É., Paragh, G., Harangi, M., Somodi, S.: Az organokinek szintjének vizsgálata elhízott 2-es típusú diabéteszes és elhízott nem diabéteszes betegekben.
Diabetol. Hung. 31 (Supplement), 48-49, 2023.

Lőrincz, H., Somodi, S., Ratku, B., Harangi, M., Paragh, G.: Crucial Regulatory Role of Organokines in Relation to Metabolic Changes in Non-Diabetic Obesity.
Metabolites. 13 (2), 1-27, 2023.

Karamercan, M., Dündar, D., Slagman, A., Ergin, M., Janssens, K., Fabbri, A., Bjornsen, L., Somodi, S., Adam, V., Polyzogopoulou, E., Demir, H., Laribi, S., EGERS study investigators: Epidemiology of geriatric patients presenting to emergency departments in Europe: EGERS study.
Eur. J. Emerg. Med. 30 (2), 117-124, 2023.

Lőrincz, H., Csiha, S., Ratku, B., Somodi, S., Sztanek, F., Seres, I., Paragh, G., Harangi, M.: Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients.
Int. J. Mol. Sci. 24 (22), 1-13, 2023.

Képes, Z., Mikó, M., Kukuts, K., Esze, R., Barna, S., Somodi, S., Káplár, M., Varga, J., Garai, I.: Imaging with [99mTc]HMPAO - a novel perspective: investigation of [99mTc] HMPAO leg muscle uptake in metabolic diseases.
Acta Radiol. 64 (1), 187-194, 2023.

Lőrincz, H., Ratku, B., Csiha, S., Seres, I., Szabó, Z., Paragh, G., Harangi, M., Somodi, S.: Impaired Organokine Regulation in Non-Diabetic Obese Subjects: halfway to the Cardiometabolic Danger Zone.
Int. J. Mol. Sci. 24 (4), 1-13, 2023.

Juhász, I., Ujfalusi, S., Seres, I., Lőrincz, H., Varga, V., Paragh, G., Somodi, S., Harangi, M., Paragh, G.: Afamin Levels and Their Correlation with Oxidative and Lipid Parameters in Non-diabetic, Obese Patients.
Biomolecules. 12 (1), 1-11, 2022.

Ratku, B., Lőrincz, H., Barth, A., Zelei, A., Somodi, S.: Az afamin, mint potenciális biomarker az elhízott betegek és a 2-es típusú cukorbetegek gondozásában.
In: XIV. Nemzetközi nyíregyházi doktorandusz és posztdoktori konferencia : Absztraktkötet. Szerk.: Rusinné Fedor Anita, Tóth Dalma, Zakor-Broda Rita, Debreceni Egyetem Egészségügyi Kar, Nyíregyháza, 55, 2022. ISBN: 9789634904755

Köbling, T., Maroda, L., Katona, É., Váradi, Z., Somodi, S., Páll, D., Zrínyi, M.: Discriminating low to high adherent type 2 patients with diabetes by glycosylated hemoglobin A1c, eating self-efficacy and other psychosocial determinants: difference between patient and physician adherence models.
Patient Prefer. Adher. 16 1405-1414, 2022.

Ratku, B., Borbásné Sebestyén, V., Erdei, A., Nagy, E., Szabó, Z., Somodi, S.: Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile.
Pituitary. 25 (2), 211-228, 2022.

Nokhoijav, E., Guba, A., Kumar, A., Kunkli, B., Kalló, G., Káplár, M., Somodi, S., Garai, I., Csutak, A., Tóth, N., Emri, M., Tőzsér, J., Csősz, É.: Metabolomic Analysis of Serum and Tear Samples from Patients with Obesity and Type 2 Diabetes Mellitus.
Int. J. Mol. Sci. 23 1-19, 2022.

Lőrincz, H., Galgóczi, E., Katkó, M., Ratku, B., Ötvös, T., Harangi, M., Paragh, G., Szabó, Z., Somodi, S.: Plasminogen activator inhibitor-1 level associated with the components of metabolic syndrome in a 4G/5G polymorphism dependent manner.
Atherosclerosis. 355 e248, 2022.

Cogoi, B., Esze, R., Rajnai, L., Somodi, S., Shemirani, A., Bereczky, Z., Paragh, G., Katkó, M., Káplár, M.: Protective effect of factor XIII Intron-K G allele on subclinical atherosclerosis.

Képes, Z., Nagy, F., Budai, Á., Barna, S., Esze, R., Somodi, S., Káplár, M., Garai, I., Varga, J.: Age, BMI and diabetes as independent predictors of brain hypoperfusion.
Nucl Med Rev Cent East Eur. 24 (1), 11-15, 2021.

Képes, Z., Aranyi, S., Forgács, A., Nagy, F., Kukuts, K., Hascsi, Z., Esze, R., Somodi, S., Káplár, M., Varga, J., Emri, M., Garai, I.: Glucose-level dependent brain hypometabolism in type 2 diabetes mellitus and obesity.
Eur. J. Hybrid Imaging. 5 (1), 1-15, 2021.

Képes, Z., Aranyi, S., Forgács, A., Nagy, F., Kukuts, K., Esze, R., Somodi, S., Káplár, M., Varga, J., Emri, M., Garai, I.: Homocysteine-related alterations of [18F]FDG brain pattern in metabolic diseases.
Hell. J. Nucl. Med. 24 (3), 222-227, 2021.

Lőrincz, H., Csige, I., Harangi, M., Szentpéteri, A., Seres, I., Szabó, Z., Paragh, G., Somodi, S.: Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects.
Life (Basel). 11 (9), 1-13, 2021.

Lőrincz, H., Csige, I., Harangi, M., Szentpéteri, A., Seres, I., Szabó, Z., Paragh, G., Somodi, S.: Serum fetuin-A and retinol-binding protein 4 correlate with lipoprotein subfractions in obese and lean non-diabetic subjects.
Atherosclerosis. 331 e201, 2021.

Esze, R., Rajnai, L., Balkay, L., Képes, Z., Somodi, S., Emri, M., Garai, I., Káplár, M.: The role of visceral and subcutaneous adipose tissue distribution determined by CT in the development of subclinical atherosclerosis in type 2 diabetes and obesit.

Esze, R., Balkay, L., Emri, M., Képes, Z., Rajnai, L., Somodi, S., Garai, I., Káplár, M.: A viszcerális és szubkután zsírszöveti eloszlás szerepe a szubklinikus atherosclerosis kialakulásában 2-es típusú diabetes mellitusban és obezitásban.
Diabetol. Hung. 28 (Suppl1), 23-24, 2020.

Káplár, M., Rajnai, L., Esze, R., Képes, Z., Emri, M., Mikó, M., Varga, J., Somodi, S., Garai, I.: Az agyi és perifériás mikrocirkuláció, valamint az arteria carotis intima-media vastagság vizsgálata diabeteses betegekben és obezitásban.
Diabetol. Hung. 28 (Suppl1), 59-60, 2020.

Balogh, B., Somodi, S., Tanyi, M., Miszti, C., Márton, I., Kelentey, B.: Follow-up Study of Microflora Changes in Crevicular Gingival Fluid in Obese Subjects After Bariatric Surgery.
Obes. Surg. 30 (12), 5157-5161, 2020.

Köbling, T., Váradi, Z., Katona, É., Somodi, S., Kempler, P., Páll, D., Zrínyi, M.: Predictors of dietary self-efficacy in high glycosylated hemoglobin A1c type 2 diabetic patients.
J. Int. Med. Res. 48 (6), 1-12, 2020.

Káplár, M., Képes, Z., Emri, M., Mikó, M., Varga, J., Somodi, S., Esze, R., Rajnai, L., Garai, I.: Alteration of cerebral and peripheral microcirculation in diabetes mellitus and obesity.

Juhász, I., Ujfalusi, S., Lőrincz, H., Varga, V., Somodi, S., Harangi, M., Seres, I., Paragh, G.: Circulating Afamin Level Correlates With Lipoprotein Subpopulations In Non-Diabetic Obese Patients.
Atherosclerosis. 287 e165, 2019.

Lőrincz, H., Szentpéteri, A., Somodi, S., Harangi, M., Fülöp, P., Paragh, G., Seres, I.: Elevated Plasminogen Activator Inhibitor-1 Level Correlates With Low-Density Lipoprotein Subfractions In Obesity.
Atherosclerosis. 287 e165, 2019.

Kiss, R., Szabó, K., Gesztelyi, R., Somodi, S., Kovács, P., Szabó, Z., Németh, J., Priksz, D., Kurucz, A., Juhász, B., Szilvássy, Z.: Insulin-Sensitizer Effects of Fenugreek Seeds in Parallel with Changes in Plasma MCH Levels in Healthy Volunteers.
Int. J. Mol. Sci. 19 (3), 1-17, 2018.

Somodi, S.: Metabolikus szindróma.
Háziorv. Továbbk. Szle. 23 (3), 117-120, 2018.

Somodi, S., Seres, I., Lőrincz, H., Harangi, M., Fülöp, P., Paragh, G.: Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese non-diabetic subjects.
Int. J. Endocrinol. 2018 1-9, 2018.

Szentpéteri, A., Lőrincz, H., Somodi, S., Varga, V., Paragh, G., Seres, I., Paragh, G., Harangi, M.: Serum obestatin level strongly correlates with lipoprotein subfractions in non-diabetic obese patients.
Lipids Health Dis. 17 (1), 1-27, 2018.

Vörös, O., Szilágyi, O., Balajthy, A., Somodi, S., Panyi, G., Hajdu, P.: The C-terminal HRET sequence of Kv1.3 regulates gating rather than targeting of Kv1.3 to the plasma membrane.
Sci Rep. 8 (1), 1-14, 2018.

Csige, I., Ujvárosy, D., Szabó, Z., Lőrincz, I., Paragh, G., Harangi, M., Somodi, S.: The Impact of Obesity on the Cardiovascular System.
J. Diabetes Res. 2018 1-12, 2018.

Balajthy, A., Pethő, Z., Somodi, S., Varga, Z., Péter, M., Vígh, L., P. Szabó, G., Paragh, G., Panyi, G., Hajdu, P.: 7-Dehydrocholesterol Modifies the Operation of Kv1.3 Channels in T Cells Isolated from Smith-Lemli-Opitz Syndrome Patients.
Biophys. J. 110 (3), 278a-279a, 2016.

Balajthy, A., Somodi, S., Pethő, Z., Péter, M., Varga, Z., P. Szabó, G., Paragh, G., Vígh, L., Panyi, G., Hajdu, P.: 7DHC-induced changes of Kv1.3 operation contributes to modified T cell function in Smith-Lemli-Opitz syndrome.
Pflügers Arch. 468 (8), 1403-1418, 2016.

Káplár, M., Sweni, S., Kulcsár, J., Cogoi, B., Esze, R., Somodi, S., Papp, M., Oláh, L., Magyar, M., Szabó, K., Czuriga-Kovács, K., Hársfalvi, J., Paragh, G.: Mannose-binding lectin levels and carotid intima-media thickness in type 2 diabetic patients.
J. Diabetes Res. 2016 (8132925), 1-8, 2016.

Paragh, G., Somodi, S.: Sport hatása az anyagcsere-betegségekre..
Metabolizmus. 14 (2), 95-99, 2016.

Pethő, Z., Balajthy, A., Bartók, Á., Bene, K., Somodi, S., Szilágyi, O., Rajnavölgyi, É., Panyi, G., Varga, Z.: The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation.
Immunol. Lett. 171 60-69, 2016.

Lőrincz, H., Harangi, M., Oláh, A., P. Szabó, G., Fülöp, P., Somodi, S., Paragh, G., Seres, I.: Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.
Pediatr. Res. 77 703-709, 2015.

Lőrincz, H., Harangi, M., Oláh, A., P. Szabó, G., Somodi, S., Paragh, G., Seres, I.: Altered distribution of lipid subfractions and decreased paraoxonase-1 activity in children with Smith-Lemli-Opitz syndrome.
Atherosclerosis. 235 e57, 2014.

Fülöp, P., Seres, I., Lőrincz, H., Harangi, M., Somodi, S., Paragh, G.: Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients.
J. Cell. Mol. Med. 18 (7), 1313-1320, 2014.

Seres, I., Lőrincz, H., Katkó, M., Harangi, M., Somodi, S., Gaál, K., Fülöp, P., Paragh, G.: Associations of chemerin levels and lipid subfractions in non-diabetic obese and lean subjects.
Atherosclerosis. 235 e220, 2014.

Bartók, Á., Tóth, Á., Somodi, S., Szántó, G., Hajdu, P., Panyi, G., Varga, Z.: Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
Toxicon. 87 6-16, 2014.

Seres, I., Harangi, M., Katkó, M., Lőrincz, H., Somodi, S., Fülöp, P., Paragh, G.: Relationship of chemerin to serum paraoxonase1 activity in metabolically healthy, obese patients.
In: EAS 2013 : 81st Congress of the European Atherosclerosis Society. Lyon, France, 2013.06.02 -2013.06.05. / [eds. EAS], EAS, [Lyon], , 2014.

Lőrincz, H., Katkó, M., Harangi, M., Somodi, S., Gaál, K., Fülöp, P., Paragh, G., Seres, I.: Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects.
Clin. Endocrinol. 81 (3), 370-377, 2014.

Somodi, S., Balajthy, A., Szilágyi, O., Pethő, Z., Harangi, M., Paragh, G., Panyi, G., Hajdu, P.: Analysis of the K+ current in human CD4+ T lymphocytes in hypercholesterolemic state.
Cell. Immunol. 281 (1), 20-26, 2013.

Szűcs, A., Batta, J., Somodi, S., Tóth, A., Szigeti, G., Csernoch, L., Panyi, G., Sziklai, I.: A Deiters sejtek kifelé irányuló K+ áramának karakterizálása.
Fül-Orr-Gégegyógy. 55 (1), 28-33, 2009.

Szűcs, A., Batta, J., Somodi, S., Tóth, A., Szigeti, G., Csernoch, L., Panyi, G., Sziklai, I.: Az eltérő morfológiai típusú Deiters sejtek elektrofiziológiai különbségei és szerepük a belső fülben.
Fül-Orr-Gégegyógy. 55 (2), 63-67, 2009.

Somodi, S., Hajdu, P., Gáspár, R., Panyi, G., Varga, Z.: Effects of changes in extracellular pH and potassium concentration on Kv1.3 inactivation.
Eur. Biophys. J. 37 (7), 1145-1156, 2008.

Szűcs, A., Somodi, S., Batta, J., Tóth, A., Szigeti, G., Csernoch, L., Panyi, G., Sziklai, I.: Differential expression of potassium currents in Deiters cells of the guinea pig cochlea.
Pflügers Arch. 452 (3), 332-341, 2006.

Varga, Z., Somodi, S., Gáspár, R., Panyi, G.: Effect of extra- and intracellular potassium on the pH-dependent modulation of Kv1.3 inactivation.
Biophys. J. 90 (Suppl), 1172, 2006.

Bagdány, M., Batista, C., Valdez-Cruz, N., Somodi, S., Rodriguez de, l., Licea, A., Varga, Z., Gáspár, R., Possani, L., Panyi, G.: Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
Mol. Pharmacol. 67 (4), 1034-1044, 2005.

Olamendi-Portugal, T., Somodi, S., Fernandez, J., Zamudio, F., Becerril, B., Varga, Z., Panyi, G., Gáspár, R., Possani, L.: Novel alpha-KTx peptides from the venom of the scorpion Centruroides elegans selectively blockade Kv1.3 over IKCa1 K+ channels of T cells.
Toxicon. 46 (4), 418-429, 2005.

Somodi, S., Varga, Z., Levy, D., Gáspár, R., Panyi, G.: The role of His399 in the pH-dependent modulation of Kv1.3 inactivation.
Biophys. J. 88 (1), 278A, 2005.

Varga, Z., Valdez-Cruz, N., Bagdány, M., Somodi, S., Gáspár, R., Possani, L., Panyi, G.: Anurotoxin: a potent and selective blocker of Kv1.3 channels.
Biophys. J. 86 (1), 538A, 2004.

Szűcs, A., Somodi, S., Batta, J., Karosi, T., Tóth, A., Csernoch, L., Panyi, G., Sziklai, I.: Characterization of potassium currents and morphology of guinea pig Deiters cells (P34).
In: Inner Ear Biology Workshop. Ed.: Sziklai István, University of Debrecen, Debrecen, 25, 2004.

Hajas, G., Zsíros, E., László, T., Hajdu, P., Somodi, S., Réthi, B., Gogolák, P., Ludányi, K., Panyi, G., Rajnavölgyi, É.: New phenotypic, functional and electrophysiological characteristics of KG-1 cells.
Immunol. Lett. 92 (1-2), 97-106, 2004.

Somodi, S., Varga, Z., Hajdu, P., Starkus, J., Levy, D., Gáspár, R., Panyi, G.: pH-dependent modulation of Kv1.3 inactivation: role of His399.
Am. J. Physiol. Cell Physiol. 287 (4), C1067-C1076, 2004.

Somodi, S., Hajdu, P., Varga, Z., Gáspár, R., Panyi, G.: C-type inactivation of Kv1.3 channels: combined effects of extracellular pH,K+ concentration and ionic strength.
Biophys. J. 84 (2), B240, 2003.

Panyi, G., Somodi, S., Varga, Z., Hajdu, P., Pieri, C., Pandi-Perumal, S., Damjanovich, S., Gáspár, R., Hardar, C., Singaravel, M., Maitra, S.: Pharmacological effects of melatonin on ion channels.
In: Treatise on Pineal Gland and Melatonin, Science Publishers Inc., Enfield, USA, 489-506, 2002.